• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们如何知道某种暴露在人类身上是否真的具有致畸性?

How do we know if an exposure is actually teratogenic in humans?

机构信息

Medical Genetics Research Unit, University of British Columbia, Children's & Women's Hospital, 4500 Oak Street, Vancouver, British Columbia, Canada.

出版信息

Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):170-4. doi: 10.1002/ajmg.c.30302. Epub 2011 Jul 15.

DOI:10.1002/ajmg.c.30302
PMID:21766430
Abstract

The only way we can be certain that an exposure is teratogenic in humans is to recognize that it causes birth defects in babies. The goal of clinical teratology research is, therefore, to identify when a teratogenic exposure has harmed babies as quickly and effectively as possible. We use several kinds of human data to characterize teratogenic effects-case reports, case series, pregnancy registries, cohort studies, case-control studies, and record linkage studies. Each approach can be helpful, but each has limitations as well. Drawing a causal inference requires analysis of all available data, their consistency, and their biological plausibility.

摘要

我们能够确定某种暴露对人类具有致畸性的唯一方法是认识到它会导致婴儿出现出生缺陷。因此,临床致畸学研究的目标是尽快、尽可能有效地识别出致畸性暴露对婴儿造成的伤害。我们使用多种人类数据来描述致畸效应——病例报告、病例系列、妊娠登记、队列研究、病例对照研究和记录链接研究。每种方法都可能有帮助,但也都有其局限性。得出因果推论需要对所有可用数据进行分析,包括它们的一致性和生物学合理性。

相似文献

1
How do we know if an exposure is actually teratogenic in humans?我们如何知道某种暴露在人类身上是否真的具有致畸性?
Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):170-4. doi: 10.1002/ajmg.c.30302. Epub 2011 Jul 15.
2
The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology.基于匈牙利经验评估药物暴露致人类致畸/胚胎毒性风险:对人类畸形学临床和流行病学模型的批判性评价。
Expert Opin Drug Saf. 2009 May;8(3):283-303. doi: 10.1517/14740330902916459.
3
Big risks in small groups: The difference between epidemiology and counselling.小群体中的重大风险:流行病学与咨询的差异
Birth Defects Res A Clin Mol Teratol. 2009 Aug;85(8):720-4. doi: 10.1002/bdra.20606.
4
[Wilson's principles--a base of modern teratology].[威尔逊原理——现代致畸学的基础]
Pol Merkur Lekarski. 2006 Mar;20(117):358-61.
5
[Teratogenic and embryotoxic effects of caffeine: facts and hypotheses].[咖啡因的致畸和胚胎毒性作用:事实与假说]
Pol Merkur Lekarski. 2000 Oct;9(52):726-8.
6
Human teratogens: update 2010.人类致畸物:2010年更新
Birth Defects Res A Clin Mol Teratol. 2011 Jan;91(1):1-7. doi: 10.1002/bdra.20748. Epub 2011 Jan 6.
7
Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.人类先天性畸形的环境成因:儿科医生在应对由多种环境和遗传因素引发的这些复杂临床问题中的作用。
Pediatrics. 2004 Apr;113(4 Suppl):957-68.
8
Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens.小型队列研究在识别新的人类致畸物中对轻微结构缺陷进行体格检查的价值。
Congenit Anom (Kyoto). 2011 Mar;51(1):16-20. doi: 10.1111/j.1741-4520.2010.00310.x.
9
The importance of dysmorphology in the identification of new human teratogens.畸形学在识别新的人类致畸物中的重要性。
Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):188-94. doi: 10.1002/ajmg.c.30311. Epub 2011 Jul 15.
10
Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.产前暴露于致畸性药物时代的风险评估和缓解策略。
Am J Obstet Gynecol. 2022 Aug;227(2):263.e1-263.e38. doi: 10.1016/j.ajog.2022.01.004. Epub 2022 Jan 12.

引用本文的文献

1
Drug safety in pregnancy.孕期用药安全
Aust Prescr. 2025 Feb;48(1):5-9. doi: 10.18773/austprescr.2025.008.
2
Knowledge and practice of community pharmacists regarding the safety of drugs during pregnancy: a cross-sectional study from a developing country.发展中国家社区药剂师关于孕期用药安全性的知识与实践:一项横断面研究
BMC Pregnancy Childbirth. 2024 Mar 11;24(1):189. doi: 10.1186/s12884-024-06393-3.
3
Identifying Human Teratogens: An Update.识别人类致畸物:最新进展
J Pediatr Genet. 2015 Jun;4(2):39-41. doi: 10.1055/s-0035-1556745.
4
Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: a validation study in the Netherlands.使用纸质问卷评估孕妇用药史的回顾性报告:荷兰的验证性研究。
Drug Saf. 2013 Jan;36(1):43-54. doi: 10.1007/s40264-012-0004-8.